Medicare Enrolled
Dr. Scott Mathis, APRN,BC
Physician Assistant · Waycross, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mathis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mathis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mathis
Dr. Scott Mathis is a physician assistant in Waycross, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mathis performed 1,800 Medicare services across 1,109 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mathis received a total of $2,273 from 34 pharmaceutical and/or device companies across 142 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mathis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 6% volume in GA
$2,273 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,800
Medicare services
Top 6% in GA for physician assistant
1,109
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~100 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
378 | $67 | $323 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
300 | $8 | $17 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
210 | $46 | $220 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
163 | $1 | $10 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
113 | $102 | $463 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
107 | $8 | $75 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
74 | $0 | $5 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
69 | $16 | $90 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
68 | $31 | $132 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
56 | $29 | $50 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
53 | $2 | $9 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
53 | $72 | $210 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
34 | $49 | $154 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
29 | $16 | $50 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
28 | $8 | $39 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
19 | $9 | $40 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
17 | $7 | $51 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
15 | $17 | $104 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $61 | $327 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$2,273
Total received (2021-2024)
Avg $758/year across 3 years
Top 17% in GA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
142
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,258 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,082
2022
$13
2021
$1,177
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$136
PFIZER INC.
$109
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
Novo Nordisk Inc
$72
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$68
Astellas Pharma US Inc
$67
Amgen Inc.
$62
Antares Pharma, Inc.
$54
GlaxoSmithKline, LLC.
$47
E.R. Squibb & Sons, L.L.C.
$39
Dexcom, Inc.
$38
ABBVIE INC.
$34
Phathom Pharmaceuticals, Inc.
$34
Boston Scientific Corporation
$30
IDORSIA PHARMACEUTICALS US INC
$30
Paratek Pharmaceuticals, Inc.
$26
Organogenesis Inc.
$26
Exact Sciences Corporation
$24
Takeda Pharmaceuticals U.S.A., Inc.
$22
Noven Therapeutics, LLC
$22
Corcept Therapeutics
$19
Indivior Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Lilly USA, LLC
$14
Top 3 companies account for 29.9% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$226
Amgen Inc.
$203
GlaxoSmithKline, LLC.
$192
AbbVie Inc.
$177
AstraZeneca Pharmaceuticals LP
$152
PFIZER INC.
$148
Astellas Pharma US Inc
$137
Boehringer Ingelheim Pharmaceuticals, Inc.
$128
BOSTON SCIENTIFIC CORPORATION
$123
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$121
Antares Pharma, Inc.
$76
Merck Sharp & Dohme Corporation
$49
E.R. Squibb & Sons, L.L.C.
$39
Lilly USA, LLC
$39
Dexcom, Inc.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$34
ABBVIE INC.
$34
Phathom Pharmaceuticals, Inc.
$34
Boston Scientific Corporation
$30
IDORSIA PHARMACEUTICALS US INC
$30
Paratek Pharmaceuticals, Inc.
$26
Organogenesis Inc.
$26
Exact Sciences Corporation
$24
Noven Therapeutics, LLC
$22
DEXCOM, INC.
$21
Ultragenyx Pharmaceutical Inc.
$20
Corcept Therapeutics
$19
SANOFI-AVENTIS U.S. LLC
$18
Indivior Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
McKesson Medical-Surgical, Inc.
$15
Biohaven Pharmaceuticals, Inc.
$14
Xeris Pharmaceuticals, Inc.
$13
Genentech USA, Inc.
$12
Top 3 companies account for 27.3% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO ELLIPTA · Aimovig · BELSOMRA · BREZTRI · CAMZYOS · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · EVENITY · FARXIGA · GENERAL PAIN MANAGEMENT · JARDIANCE · KEVEYIS · Kerendia · Korlym · LINZESS · MYRBETRIQ · NURTEC ODT · NUZYRA · Otezla · Ozempic · PREMARIN · PURAPLY AM · QULIPTA · QUVIVIQ · RYBELSUS · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · SUBLOCADE · SYNJARDY · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · UBRELVY · VOQUEZNA · VRAYLAR · Veozah · Wegovy · XIFAXAN · XYOSTED · Xelstrym · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Physician assistants within 10 mi
33
Per 100K population
91.8
County median income
$44,833
Nearest hospital
Memorial Satilla Health
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mathis is a clinical cardiology specialist, with above-average Medicare volume (top 6% in GA), with low-engagement industry engagement in the top 17% of GA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mathis experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mathis performed 378 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mathis receive payments from pharmaceutical companies?
Yes. Dr. Mathis received a total of $2,273 from 34 companies across 142 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mathis's costs compare to other physician assistants in Waycross?
Dr. Mathis's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mathis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Physician Assistants in Waycross
Browse physician assistants in Waycross ranked by procedure volume and transparency data.
Highest volume
Top Physician Assistants in GA
Physician assistants ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Physician Assistants in GA
Which GA physician assistants receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology